Daily BriefsFinancials

Daily Brief Financials: Hankyu Hanshin REIT, Inc., Korea Stock Exchange KOSPI 200, KE Holdings , Korea Stock Exchange Kospi Index, Manappuram Finance, Spectral AI and more

In today’s briefing:

  • Hankyu Hanshin REIT (8977) – Good Fundamental News, a Bigly Buyback, and Cascading Flows to Come
  • Short Selling Resumes in Korea Just as the KOSPI 200 Braces for Pullback (Perfect Timing!)
  • [KE Holdings (BEKE US, BUY, TP US$25) Earnings Review]: Housing Inventory Resolution Drives Recovery
  • Korea’s FSC Just Dropped the Final Playbook on the Full Restart of Short Selling.
  • Manappuram Finance: Bain Capital’s Entry Signals a New Chapter, But Challenges Remain
  • MDAI: Burn Study Topline Data


Hankyu Hanshin REIT (8977) – Good Fundamental News, a Bigly Buyback, and Cascading Flows to Come

By Travis Lundy

  • 3D Investment Partners launched a Partial Tender Offer to buy a 10+% stake in Hankyu Hanshin REIT, Inc. (8977 JP). The REIT finally responded with a “Neutral” stance. 
  • But they also upgraded earnings forecasts, bought a building, and announced the Sponsor would buy units in the market over the next year. It’s big. 
  • And that creates flows, which then engender other reactive flows, and cascading flows, and because the sector isn’t rich, there may be a tailwind.

Short Selling Resumes in Korea Just as the KOSPI 200 Braces for Pullback (Perfect Timing!)

By Nico Rosti

  • Short selling in all stocks in South Korea will resume from 31 March 2025. The KOSPI 200 (KOSPI2 INDEX EQUITY) is approaching the overboughtarea according to our models.
  • If the KOSPI 200 can rise for another week, it would be perfectly ripe for a large, high probability SHORT trade.
  • The probability of WEEKLY reversal in the range between the last Close (355) and the 363 resistance limit is between 50% and 75%, pretty high.

[KE Holdings (BEKE US, BUY, TP US$25) Earnings Review]: Housing Inventory Resolution Drives Recovery

By Eric Wen

  • Beike reported C4Q24 revenue beat our estimate/consensus by 8.4%/7.4%, non-GAAP OP miss our estimate/consensus by 37.5%/21.6%, due to front-loading expansion cost.
  • We expect Beike to take 2-3ppt of market share in a rebalancing property market in 2025. 
  • We keep the stock as BUY and keep TP at US$25.

Korea’s FSC Just Dropped the Final Playbook on the Full Restart of Short Selling.

By Sanghyun Park

  • Today’s update clarifies which brokers are fully linked to NSDS, giving them an edge in short-selling speed and flexibility, while others face more execution constraints.
  • This leads to a clear execution risk gap, requiring traders to factor in trade efficiency differences based on their broker.
  • With lower short-selling restriction triggers, liquidity and short-covering dynamics will shift, requiring traders to reassess market impact and adjust strategies accordingly.

Manappuram Finance: Bain Capital’s Entry Signals a New Chapter, But Challenges Remain

By Nimish Maheshwari

  • Bain Capital is acquiring a 41.7–46% stake in Manappuram Finance (MGFL IN), marking a shift from a promoter-led to a professionally managed NBFC.
  • This deal injects INR 4,385 crore in fresh capital, strengthens governance, and positions Manappuram for growth beyond gold loans into microfinance, vehicle loans, and housing finance.
  • While execution risks remain, Bain’s track record in financial services suggests a long-term transformation, potentially closing Manappuram’s valuation gap with Muthoot Finance.

MDAI: Burn Study Topline Data

By Zacks Small Cap Research

  • Spectral AI is developing an AI-guided predictive medical device that employs multispectral imaging (MSI) to estimate a wound’s capacity to heal.
  • The company is pursuing indications in burn and diabetic foot ulcers (DFUs) with the former receiving support from BARDA & other government agencies.
  • Spectral is distinguished by its combination of MSI and AI to improve diagnoses.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars